Análisis económico de acontecimientos adversos producidos por sunitinib, bevacizumab + interferón alfa e interferón alfa en pacientes con carcinoma de células renales metastásico en México
M. Ramírez, Gustavo Peniche, J. Rodríguez, Carlos Nuño-Langre, E. Muciño-Ortega, J. Mould-Quevedo
{"title":"Análisis económico de acontecimientos adversos producidos por sunitinib, bevacizumab + interferón alfa e interferón alfa en pacientes con carcinoma de células renales metastásico en México","authors":"M. Ramírez, Gustavo Peniche, J. Rodríguez, Carlos Nuño-Langre, E. Muciño-Ortega, J. Mould-Quevedo","doi":"10.1007/BF03320883","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"16 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PharmacoEconomics Spanish Research Articles","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF03320883","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
